1. Agouridas, C., Bonnefoy, A., & Chantot, J. F. (1998). In vitro activity of HMR 3647, a novel ketolide highly active against respiratory pathogens [abstract 1.11]. 4th International Conference on the Macrolides, Azalides, Streptogramins and Ketolides; January 21-23; Barcelona, Spain
2. Appelbaum, P. C., Kelly, L. M., Hryniewicz, W., Drukalska, L., Hupkova, H., Kolman, J., Mieivleviciene, J., Pana, M., Setchanova, L., Tambic, A., Thege, M. K., Trupl, J., & Urbaskova, P. (2000). Activity of telithromycin (HMR 3647) against 300 S. pyogenes from ten central and eastern European countries [abstract 2153]. 40th Interscience Conference on Antimicrobial Agents and Chemotherapy; September 17–20; Toronto, Canada
3. In vitro activities of the ketolide HMR 3647 against recent Gram-positive clinical isolates and Haemophilus influenzae;Barry;Antimicrob Agents Chemother,1998
4. Decreased susceptibility of Streptococcus pneumoniae to fluoroquinolones in Canada. Canadian Bacterial Surveillance Network;Chen;N Engl J Med,1999
5. Cocuzza, C. E., Tomasin, A., Renzetti, D., Primavera, A., Santini, L., Marchetti, F., Mattina, R. (1998). Ketolide (HMR 3647) in vitro activity on 4000 strains of Streptococcus pyogenes isolated in northern Italy [abstract 1.06]. 4th International Conference on the Macrolides, Azalides, Streptogramins and Ketolides; January 21–23; Barcelona, Spain